Search For

Roles and potential applications of non-coding RNAs in cancer treatment with immune checkpoint inhibitors and immunomodulatory therapies

Multi-omics classification of acute myeloid leukemia guides drug combinations to overcome Venetoclax resistance

Immunotherapy resistance and strategies in malignant pleural mesothelioma

Conjugated oligoelectrolytes overcome cancer drug resistance by dual-mode lysosomal membrane disruption

From EGFR PTM network to TKI resistance: spatial subtypes and targeting in lung cancer

TROP2-targeting antibody–drug conjugates in breast cancer and ovarian carcinoma: therapeutic advances and resistance mechanisms

Evaluation of intracellular nucleotide pools in peripheral blood and bone marrow mononuclear cells and their association with frontline intensive chemotherapy response rates in AML patients

Extracellular vesicles shed by multidrug resistant cells contribute to the identification of SRC inhibitors as chemosensitizers in non-small cell lung cancer

Novel anti-tumor strategies: targeting the crosstalk between cancer stem cells and cancer-associated fibroblasts to resist drug resistance

Identification of antibody-drug conjugate payloads that are substrates of ATP-binding cassette drug efflux transporters

Circular RNA hsa-circ-0001030 suppresses proliferation and cisplatin tolerance in TSCC via interaction with PKM2

MicroRNAs as key regulators of cancer drug resistance: insights and future directions in chemotherapy, targeted-therapy, radiotherapy, and immunotherapy